Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Efficacy Trial of Pazopanib in Non-clear Cell Metastatic Renal Cell Cancer (mRCC) PINCR

NCT01767636 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT01767636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01767636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Efficacy Trial of Pazopanib in Non-clear Cell Metastatic Renal Cell Cancer (mRCC) PINCR
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Completed
Start date
May 16, 2013
Completion date
January 20, 2021
Enrollment
38 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma of the collecting ducts of bellini, chromophobe renal cell carcinoma, kidney medullary carcinoma, kidney oncocytoma, metastatic renal cell cancer, papillary renal cell carcinoma, recurrent renal cell carcinoma, sarcomatoid renal cell carcinoma, stage iv renal cell cancer